Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 1Active not recruiting 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Conditions

Carcinoma, Renal Cell 10Neoplasms 8Neoplasm Metastasis 8Endometrial Neoplasms 6Breast Neoplasms 6Brain Neoplasms 5Unspecified Adult Solid Tumor, Protocol Specific 4Prostatic Neoplasms 4Melanoma 4Lymphoma 4Kidney Neoplasms 4Glioblastoma 4Advanced Cancer 4Uterine Cervical Neoplasms 3Sarcoma 3Recurrence 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Multiple Myeloma 3Glioma 3Central Nervous System Neoplasms 3Unspecified Childhood Solid Tumor, Protocol Specific 2Solid Tumors 2Small Cell Lung Carcinoma 2Resistant Solid Malignancies 2Pinealoma 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Oligodendroglioma 2Lymphoma, Mantle-Cell 2Lung Neoplasms 2

Interventions

temsirolimus 2Sirolimus 2Gemcitabine 2ARQ 197 2veliparib 1sargramostim 1pegfilgrastim 1ixabepilone 1cixutumumab 1belinostat 1Vorinostat 1Topotecan 1Tolbutamide 1Taxes 1Sunitinib 1Rifampin 1Paclitaxel 1Omeprazole 1Midazolam 1Ketoconazole 1Isotretinoin 1Irinotecan 1Introns 1Interferon alpha-2 1Hydroxychloroquine 1Erlotinib Hydrochloride 1Epothilones 1Dextromethorphan 1Colony-Stimulating Factors 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Adult Solid Neoplasm × temsirolimus × Clear all
NCT01375829 2026-04-13

Ixabepilone and Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 1 Active not recruiting
22 enrolled

Adult Solid Neoplasm

NCT01625156 2015-10-20

Tivantinib and Temsirolimus in Treating Patients With Solid Tumors That is Metastatic or Cannot be Removed by Surgery

National Cancer Institute (NCI)

Phase 1 Completed
11 enrolled

Adult Solid Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡